| Name | Title | Contact Details |
|---|---|---|
Terri Wrin |
Director, Virology R&D | Profile |
Jackie Reeves |
Associate Vice President, Technical Director, R&D | Profile |
Insite Vision is a Alameda, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
JSJ Pharmaceuticals is a Charleston, SC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
ProNAi Therapeutics is a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform for patients with cancer and hematological diseases. ProNAi`s lead DNAi product candidate, PNT2258, is designed to treat cancers that overexpress BCL2, an important and validated oncogene known to be dysregulated in many types of cancer. ProNAi is pursuing a multi-faceted clinical development strategy designed to efficiently achieve regulatory approval and maximize the commercial opportunity of PNT2258. ProNAi recently initiated "Wolverine", a Phase 2 trial evaluating PNT2258 for the treatment of relapsed or refractory diffuse large B-cell lymphoma.
RxNT is a Annapolis, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Septodont is a New Castle, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.